Glaucoma

Top Story

Trabodenoson significantly reduced IOP in ocular hypertension, POAG

May 2, 2016

Researchers found that twice-daily ocular doses of trabodenoson were well tolerated and decreased IOP in patients with ocular hypertension or primary open-angle glaucoma.

In the multicenter, randomized, double-masked, placebo-controlled, dose-escalation phase 2 study, patients received topical twice-daily trabodenoson (50 mcg, 100 mcg or 200 mcg) or placebo for 14 days or 500 mcg trabodenoson or placebo for 28 days.

Meeting News Coverage

D-Eye increases distribution of portable retinal screening system

April 29, 2016
NEW YORK – D-Eye announced here at Vision Expo East the increased distribution of its device that attaches to a smartphone to record high-resolution images and…
In the JournalsFrom OSN Europe

European heritage linked to increased risk of optic disc hemorrhage

April 28, 2016
European descent was associated with a higher risk of optic disc hemorrhage than African descent, and African descent was associated with greater prevalence of beta-zone…

PCON remembers Larry Alexander

April 26, 2016
The American Academy of Optometry reported the April 16 passing of academy fellow and Primary Care Optometry News contributor Larry J. Alexander
Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with…
More »
Meeting News Coverage

Proactive approach to OSD improves surgical outcomes, contact lens success

April 22, 2016
NEW YORK – Do not wait for a patient to say he or she has dry eye; assess his or her risk and symptoms and…
More »
Featured
Vision Expo East

Vision Expo East

Perspectives on Glaucoma

Glaucoma patients found to have greater risk of unsafe driving

April 26, 2016
Glaucoma patients at the greatest risk for unsafe driving exhibited slower performance on psychometric and mobility…
More »
In the Journals

Trabodenoson significantly reduced IOP in ocular hypertension, POAG

May 2, 2016
Researchers found that twice-daily ocular doses of trabodenoson were well tolerated and decreased IOP in patients with ocular hypertension or primary…
Meeting News Coverage

D-Eye increases distribution of portable retinal screening system

April 29, 2016
NEW YORK – D-Eye announced here at Vision Expo East the increased distribution of its device that attaches to a smartphone to record…
In the JournalsFrom OSN Europe

European heritage linked to increased risk of optic disc hemorrhage

April 28, 2016
European descent was associated with a higher risk of optic disc hemorrhage than African descent, and African descent was associated with greater…

PCON remembers Larry Alexander

April 26, 2016
The American Academy of Optometry reported the April 16 passing of academy fellow and Primary Care Optometry News contributor Larry J
Perspectives on Glaucoma

Glaucoma patients found to have greater risk of unsafe driving

April 26, 2016
Glaucoma patients at the greatest risk for unsafe driving exhibited slower performance on psychometric and mobility testing, according to researchers…
Perspectives on Glaucoma

Fewer medications prior to SLT improve chance of success

April 25, 2016
One-year efficacy of selective laser trabeculoplasty in controlling intraocular pressure was limited in patients with maximal-tolerable medical…
Meeting News CoverageVideo

Device combines two tests to provide data on structure, function

April 22, 2016
NEW YORK – Diagnostic testing with the Compass perimeter from CenterVue provides “a new method for performing a test we’ve been…
Perspectives on Glaucoma

Higher glaucoma medication confidence when providers educate patients

April 21, 2016
Researchers found higher patient confidence in adhering to glaucoma medication regimens and confidence to administer eye drops correctly when…
Perspectives on Glaucoma

Prostaglandins offer greater short-term IOP reduction than other classes

April 20, 2016
Bimatoprost, latanoprost and travoprost offered the best results at 3 months for primary open-angle glaucoma in a meta-analysis of 114 randomized…
In the JournalsPerspective

Twice-daily dose of trabodenoson may lower IOP in glaucoma patients

April 18, 2016
Twice-daily 50 µg to 500 µg ocular doses of trabodenoson were well-tolerated, according to a study, and at 500 µg, a dose-related decrease in IOP was…
More Headlines »